%0 Case Reports
%T Therapeutic Options in Diffuse Large B-Cell Lymphoma - A Retrospective Study and Review of the Literature.
%A Patrascu AM
%A Nacea J
%A Patrascu Ş
%A Goganau A
%A Delcea F
%A Mogoanta L
%A Rotaru I
%J Curr Health Sci J
%V 43
%N 3
%D Jul-Sep 2017
%M 30595888
暂无%R 10.12865/CHSJ.43.03.15
%X The aim of this retrospective study was to assess the differences between standard R-CHOP and other Rituximab-associated chemotherapy (R-miniCHOP and R-CHOEP) regimens in terms of survival and potential adverse effects. The six-month survival outcomes of 94 diffuse large B-cell lymphomas (DLBCL) patients indicated no statistical difference between overall survival and disease-free survival in the two subgroups. The biological response to therapy (blood count, LDH levels) was similar in both subgroups. Despite having different clinical indications, R-miniCHOP and R-CHOEP provide viable therapeutic alternatives to the standard R-CHOP regimen.